Certificate of Analysis
Purity
≥98.0%
Method
HPLC / MS
Testing
Third-Party
COA Status
Available
cagrilintide 2.5mg+Semaglutide2.5mg
A research compound studied in laboratory models involving incretin-related signaling, metabolic pathway investigation, and compound characterization.
Choose Pack Size
Quantity
Research Use Only — All products are intended strictly for laboratory research purposes and are not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
About cagrilintide 2.5mg+Semaglutide2.5mg
This research formulation combines cagrilintide (AM833; 2.5 mg) — a long-acting amylin analog — and semaglutide (NNC-0177-0864; 2.5 mg) — a GLP-1 receptor agonist — in a single lyophilized vial. Cagrilintide activates amylin receptors (AMY1–AMY3 subtypes formed by CRLR/RAMP complexes), while semaglutide engages the GLP-1 receptor, resulting in a dual-mechanism formulation that targets two distinct incretin-related receptor systems simultaneously.
The combination has been studied in controlled research settings to investigate the pharmacodynamic interactions between amylinergic and GLP-1-ergic signaling pathways, including combined downstream cAMP signaling profiles, complementary receptor occupancy dynamics, and comparative in vitro potency measurements. This formulation is used as a research reference compound in laboratory investigations of dual incretin/amylin receptor pharmacology and is intended solely for qualified researchers conducting preclinical or in vitro studies.
Formulation Information
| Property | Value |
|---|---|
| Molecular Formula | Multi-component blend |
| Molecular Weight | Cagrilintide: ~3,907.4 g/mol | Semaglutide: 4,113.6 g/mol |
| CAS Number | N/A — Research Blend |
| Synonyms | CagriSema (research reference), Amylin/GLP-1 Dual Agonist Blend |
99%+
PURITY
Third Party Tested
Independently verified by ISO-accredited laboratories. Batch-specific COAs available on request.
GMP
CERT.
GMP Manufacturing Standards
Synthesized in registered facilities following Good Manufacturing Practices with full chain-of-custody documentation.
FAST
SHIP
Best in Class Fulfillment
Same-day fulfillment on qualifying orders. Secure cold-chain packaging. Domestic and international research shipping.
ZERO
FILLERS
Zero Fillers or Additives
Pure active compounds only. Lyophilized without fillers or preservatives. Composition independently verified.
Scientific Content Review
All technical product descriptions, molecular data, and research context on this page have been prepared with reference to published scientific literature and PubChem compound databases. Content is intended for informational purposes in a research catalog context and does not constitute medical advice or claim therapeutic efficacy.
cagrilintide 2.5mg+Semaglutide2.5mg is a research compound available for controlled laboratory investigation and scientific study. This product is intended strictly for in vitro research, preclinical investigation, and analytical characterization by qualified researchers. Not for human consumption.
Category
GLP-1 / Metabolic
Purity
≥98.0%
Available Sizes
5MG
COA
Available
Overview
cagrilintide 2.5mg+Semaglutide2.5mg is a research compound available for controlled laboratory investigation and scientific study. This product is intended strictly for in vitro research, preclinical investigation, and analytical characterization by qualified researchers. Not for human consumption.
Category
GLP-1 / Metabolic
Purity
≥98.0%
Available Sizes
5MG
COA
Available
Research Interest
Research interest includes incretin-related receptor pathway analysis, metabolic signaling cascade investigations, and comparative compound studies in in vitro and preclinical models. Areas of scientific study include receptor binding dynamics, downstream signaling effects, and compound stability characterization.
Scientific Literature Note
Research interest data is provided for scientific reference purposes only, based on published preclinical or in vitro literature. No claims regarding human therapeutic outcomes are made or implied.
Specifications
| Specification | Unit Strength | Unit | Pack Size | Total Active Qty |
|---|---|---|---|---|
| 5mg x 10vials | 5 | MG | 10 vials | 50 MG |
Quality / COA
Each batch is prepared to research-grade analytical standards. HPLC purity verification and mass spectrometry confirmation are performed for every lot. A batch-specific Certificate of Analysis (COA) is available identifying lot number, purity percentage, testing methodology, and third-party laboratory credentials.
COA Summary
Purity
≥98.0%
Testing Method
HPLC / ESI-MS
Lab Type
ISO-Accredited
Availability
On Request
HPLC purity verification
Mass spectrometry confirmation
Independent third-party lab
Lot-specific documentation
Storage
Store lyophilized compound at −20°C or below. Protect from light and moisture. Refer to the Certificate of Analysis for complete handling and storage specifications. Follow all applicable laboratory safety protocols and institutional regulations.
Temperature
−20°C or below
Long-term storage
Light
Protected
Avoid UV exposure
Form
Lyophilized
Until lab use
Disclaimer
Research Use Only — All products are intended strictly for laboratory research purposes and are not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
For laboratory research use only. Not for human consumption. This product is not intended to diagnose, treat, cure, or prevent any disease. Sold exclusively for in vitro and preclinical research applications by qualified researchers.
Products are sold exclusively for in vitro research, preclinical investigation, and laboratory study. Purchasers are responsible for compliance with all applicable laws and regulations in their jurisdiction.
GLP-1 / Metabolic
Related Research Compounds
GLP-1 Research
Tirzepatide
A dual-action research compound investigated in laboratory models involving GIP and GLP-1 receptor pathway analysis, incretin signaling dynamics, and metabolic cascade characterization.
From $45.00
GLP-1 Research
Semaglutide
A GLP-1 receptor analogue studied in research models involving incretin-related signaling pathway analysis, receptor binding dynamics, and metabolic pathway investigation.
From $55.00
GLP-1 Research
Retatrutide
A triple-receptor research agonist studied in laboratory models involving GLP-1, GIP, and glucagon receptor pathway analysis and metabolic signaling characterization.
From $85.00
GLP-1 Research
Cagrilintide
A research compound studied in laboratory models involving incretin-related signaling, metabolic pathway investigation, and compound characterization.
From $65.00